Difficulty: Medium
Average Score: 70%
Practice
Which antibiotic is not recommended as first line therapy for the associated bug?
Correct answer
C
Rationale
In this NCLEX question on infection prevention and control, the correct answer is option C) chlamydia pneumoniae - doxycycline. Doxycycline is the recommended first-line therapy for chlamydia pneumoniae infections due to its effectiveness against this specific pathogen. The other options, A) legionella - erythromycin, B) chlamydia psittaci - doxycycline, and D) mycoplasma pneumoniae - roxithromycin, are incorrect.
Option A is incorrect because erythromycin is the first-line treatment for Legionella infections, not contraindicated. Option B is incorrect as doxycycline is the preferred treatment for Chlamydia psittaci infections. Option D is incorrect as roxithromycin is commonly used to treat Mycoplasma pneumoniae infections.
In an educational context, understanding the appropriate antibiotic therapies for specific pathogens is crucial in infection prevention and control. Healthcare professionals need to be knowledgeable about which antibiotics are most effective against different types of bacteria to ensure proper treatment and reduce the risk of antibiotic resistance. This question challenges students to apply their knowledge of antibiotic therapy in the context of specific bacterial infections, preparing them for real-world clinical scenarios.
Option A is incorrect because erythromycin is the first-line treatment for Legionella infections, not contraindicated. Option B is incorrect as doxycycline is the preferred treatment for Chlamydia psittaci infections. Option D is incorrect as roxithromycin is commonly used to treat Mycoplasma pneumoniae infections.
In an educational context, understanding the appropriate antibiotic therapies for specific pathogens is crucial in infection prevention and control. Healthcare professionals need to be knowledgeable about which antibiotics are most effective against different types of bacteria to ensure proper treatment and reduce the risk of antibiotic resistance. This question challenges students to apply their knowledge of antibiotic therapy in the context of specific bacterial infections, preparing them for real-world clinical scenarios.